BioCardia to Host Q3 2026 Financial Results and Corporate Update Conference Call on November 12, 2026
Globe Newswire•09/11/2026•16:18 ET
3
Key Highlights
- ➤BioCardia will report Q3 2026 financial results November 12 at 4:30 PM EDT
- ➤Management will provide a corporate update during the conference call
- ➤BioCardia has three cardiac clinical-stage product candidates in development
SUNNYVALE, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ:BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and report its financial results for the third quarter of 2026 by conference call on Thursday, November 12, 2026 at 4:30 PM EDT. Following management’s formal remarks, there will be a question-and-answer session.
Participants can register for the conference by navigating to: https://dpregister.com/sreg/10213286/10535c5b644
Get started
Create a free account to read the full story.